<DOC>
	<DOCNO>NCT00564213</DOCNO>
	<brief_summary>To evaluate compare effect prophylactic use two different exposure time mitomycin C ( MMC ) 0.02 % inhibit haze formation photorefractive keratectomy ( PRK ) high myopia ( &gt; -7.0 D ) . Methods : Forty six eye twenty three patient , 8 men 15 woman , high myopia include prospective study . Mean age time PRK plus MMC 31.7 year . Before PRK , mean spherical equivalent -8.50 D ( range , -7.25 -10.50 D ) . In patient , one eye randomly assign PRK single intraoperative topical application mitomycin C 0.02 % 15 second ( Group 1 ) fellow eye , 30 second ( Group 2 ) .The inclusion criterion high myopia , central corneal opacity inadequate corneal thickness allow safe Laser situ keratomileusis procedure . Refraction , uncorrected visual acuity , best spectacle-corrected visual acuity ( BSCVA ) , slit-lamp evidence corneal opacity ( haze ) evaluate 12 month</brief_summary>
	<brief_title>Evaluation Prophylactic Use Mitomycin C 0.02 % Inhibit Haze Formation After Photorefractive Keratectomy High Myopia : 15 x 30 Seconds</brief_title>
	<detailed_description />
	<mesh_term>Myopia</mesh_term>
	<mesh_term>Mitomycin</mesh_term>
	<mesh_term>Mitomycins</mesh_term>
	<criteria>Myopia compound myopic astigmatism Stable refractive error No associate eye disease Diabetes , Autoimmune diseases Topographic abnormality</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2007</verification_date>
	<keyword>Myopia</keyword>
	<keyword>Mitomycin</keyword>
</DOC>